As of 2025-09-15, the EV/EBITDA ratio of Proteome Sciences PLC (PRM.L) is -15.60. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. PRM.L's latest enterprise value is 23.64 mil GBP. PRM.L's TTM EBITDA according to its financial statements is -1.51 mil GBP. Dividing these 2 quantities gives us the above PRM.L EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.9x - 21.4x | 17.4x |
| Forward P/E multiples | 11.6x - 16.5x | 13.6x |
| Fair Price | (10.61) - (12.96) | (12.46) |
| Upside | -406.8% - -474.5% | -460.0% |
| Date | EV/EBITDA |
| 2025-09-09 | -15.13 |
| 2025-09-08 | -15.31 |
| 2025-09-05 | -15.62 |
| 2025-09-04 | -15.62 |
| 2025-09-03 | -15.62 |
| 2025-09-02 | -15.62 |
| 2025-09-01 | -15.88 |
| 2025-08-29 | -15.21 |
| 2025-08-28 | -14.41 |
| 2025-08-27 | -14.90 |
| 2025-08-26 | -14.70 |
| 2025-08-22 | -14.90 |
| 2025-08-21 | -14.90 |
| 2025-08-20 | -14.70 |
| 2025-08-19 | -14.61 |
| 2025-08-18 | -14.70 |
| 2025-08-15 | -14.68 |
| 2025-08-14 | -14.70 |
| 2025-08-13 | -14.70 |
| 2025-08-12 | -14.68 |
| 2025-08-11 | -14.68 |
| 2025-08-08 | -14.55 |
| 2025-08-07 | -14.78 |
| 2025-08-06 | -14.78 |
| 2025-08-05 | -14.78 |
| 2025-08-04 | -14.78 |
| 2025-08-01 | -14.78 |
| 2025-07-31 | -14.78 |
| 2025-07-30 | -14.78 |
| 2025-07-29 | -14.78 |
| 2025-07-28 | -14.78 |
| 2025-07-25 | -14.78 |
| 2025-07-24 | -14.78 |
| 2025-07-23 | -15.17 |
| 2025-07-22 | -14.78 |
| 2025-07-21 | -14.78 |
| 2025-07-18 | -14.78 |
| 2025-07-17 | -14.78 |
| 2025-07-16 | -14.78 |
| 2025-07-15 | -14.78 |
| 2025-07-14 | -14.78 |
| 2025-07-11 | -14.78 |
| 2025-07-10 | -14.59 |
| 2025-07-09 | -14.78 |
| 2025-07-08 | -14.78 |
| 2025-07-07 | -14.76 |
| 2025-07-04 | -14.78 |
| 2025-07-03 | -14.78 |
| 2025-07-02 | -14.78 |
| 2025-07-01 | -14.78 |